Nanthealth, inc. (NH)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent

23,065

-11,749

-16,377

-14,713

-19,923

-49,122

-97,466

-23,396

-22,168

-21,634

-42,398

-70,064

-41,115

-59,951

-36,874

-54,132

-33,145

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on sale of businesses

32,211

0

0

-582

0

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

4,271

4,819

5,600

6,124

5,819

5,869

5,603

5,586

5,297

4,767

6,853

8,104

8,331

7,943

7,515

7,666

7,809

Amortization of debt discounts and deferred financing offering cost

1,542

1,495

1,447

1,403

1,357

1,316

1,273

1,235

1,194

1,157

1,121

1,088

1,051

108

0

0

0

Change in fair value of derivatives liability

-5

0

0

0

0

0

5

1

1

19

6

24

215

1,228

0

0

0

Change in fair value of Bookings Commitment

3,128

-

-3,159

989

-2,494

-

0

0

0

-

-

-

-

-

-

-

-

Unrealized changes in fair value of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-4

53

Realized changes in fair value of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

4

-53

Stock-based compensation

653

937

526

673

650

852

373

1,714

2,718

8,587

-4,963

637

250

4,970

5,194

43,690

98

Deferred income taxes, net

-227

-

-800

87

164

-

-1,809

-608

-1,177

-

6,613

142

233

-

291

-14,158

-4,885

Provision for bad debt expense

6

-84

-7

14

10

-134

88

17

36

65

-43

11

187

27

-30

442

110

Loss from related party equity method investment

-1,784

-1,916

-1,983

-2,208

-2,210

-18,897

-83,306

-2,945

-3,261

-3,981

-2,942

-38,885

-4,526

-33,101

-2,604

-2,375

-2,914

Changes in operating assets and liabilities:
Accounts receivable, net

-937

-114

-2,917

-297

12

-2,050

-1,678

4,250

-928

-504

2,705

2,421

-4,626

839

-5,198

1,010

-4,762

Inventories

18

596

-101

-113

-80

-158

-77

-74

-34

-135

-55

36

-42

435

-61

145

51

Related party receivables, net

0

-145

-222

-40

-280

-286

129

426

37

14

-772

131

4

1

-15

340

-1

Prepaid expenses and other current assets

-15,444

-3,357

18,150

736

1,100

-592

-569

-571

-538

94

328

-542

708

1,388

-2,847

-2,767

731

Accounts payable

-282

-

-

-

685

-

-

-

-

-

-

-

-

-

-

-

-

Deferred implementation costs

-

-

-

-

-

-15

1

-47

13

263

447

1,026

478

-743

580

2,713

3,402

Accounts payable

-

-

-

-

-

-679

-2,216

733

495

-886

3,020

-1,634

-2,352

-1,329

499

903

-5,717

Accrued and other current liabilities

-14,884

-2,671

22,494

-2,318

-80

-1,696

3,866

-223

-6,769

-2,194

2,096

-2,592

-3,631

2,058

1,336

1,870

-1,477

Deferred revenue

-1,433

7,447

-1,339

-2,088

1,016

16,417

-399

1,517

-588

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

354

549

-136

-1,044

4,484

Related party payables, net

1,937

2,195

1,142

897

1,727

1,012

1,184

1,110

2,720

724

-4,164

3,449

2,823

1,942

427

4,569

-2,718

Change in operating lease right-of-use assets and liabilities

-95

-121

-105

-141

-51

-

-

-

-

-

-

-

-

-

-

-

-

Other operating assets and liabilities

109

3

-24

470

159

-487

-1,241

-1,099

-239

595

-4

-243

-58

144

1

378

-450

Net cash used in operating activities

-2,743

-2,317

2,716

-4,331

-4,833

-3,285

-2,767

-10,287

-13,293

-7,679

-18,731

-28,716

-26,022

-18,487

-11,011

-9,638

-31,498

Cash flows from investing activities:
Proceeds from Divestiture of Businesses, Net of Cash Divested

46,401

0

0

300

0

-68

0

0

68

0

1,721

0

0

-

-

-

-

Acquisitions of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-698

0

0

79,423

Deferred consideration for acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

2,409

0

-455

2,404

Purchases of property and equipment, including internal-use software

935

1,095

1,407

1,115

973

1,152

4,067

4,867

460

1,080

2,240

2,946

7,370

3,079

4,470

4,061

4,170

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

31

Proceeds from sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

0

71

0

1,204

Net cash provided by (used in) investing activities

45,466

-1,095

-1,407

-815

-973

-1,152

-4,067

-4,867

-392

-1,440

-519

-2,946

-7,370

28

-4,261

-4,516

-80,016

Cash flows from financing activities:
Repayments of insurance promissory note

238

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from (payment of) related party promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

152,666

Deemed capital contribution from Chairman and CEO

-

-

-

-

-

-

-

-

-

-

-

-

-

390

1,800

1,180

440

Tax payments related to stock issued, net of stock withheld, for vested equity awards

0

0

3

209

58

61

9

1,657

339

2,595

29

605

2,106

16

5,822

0

0

Payment of short-term notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

23,324

Net cash used in financing activities

-238

-708

943

-209

-58

-61

-102

-1,657

-339

-2,595

-29

-605

-2,106

103,088

-4,022

84,746

129,782

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-77

-147

90

303

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-11

37

-2

-13

3

-38

18

-170

-110

-

103

42

39

-

-

-

-

Net increase (decrease) in cash, cash equivalents and restricted cash

42,474

-4,083

2,250

-5,368

-5,861

-4,536

-6,918

-16,981

-14,134

-11,833

-19,176

-32,225

-35,459

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

84,552

-19,441

70,682

18,571

Supplemental disclosure of cash flow information
Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

1

2

4

5

0

Interest received

-

-

-

-

-

2

8

2

1

1

32

21

9

11

13

94

1

Noncash investing and financing activities
Purchases of property and equipment including internal use software

-

-

-

-

-

-

-292

-993

1,570

-

-52

-779

1,642

1,995

967

0

0

NaviNet escrow receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,678

Accretion to redemption value of Series F / redeemable common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,333

2,625